XML 57 R21.htm IDEA: XBRL DOCUMENT
v3.22.4

Per Share Amounts | 12 Months Ended
--- | ---
Dec. 31, 2022
Earnings per share [abstract] |
Per Share Amounts |
14. PER SHARE AMOUNTS
A) Net Earnings (Loss) Per Common Share – Basic and Diluted
For the years ended December 31, | 2022 |  | 2021 |  | 2020 |  |  |  |
Net Earnings (Loss) | 6,450 |  | 587 |  | (2,379) |  |  |  |
Effect of Cumulative Dividends on Preferred Shares | (35) |  | (34) |  | — |  |  |  |
Net Earnings (Loss) – Basic and Diluted | 6,415 |  | 553 |  | (2,379) |  |  |  |
Basic – Weighted Average Number of Shares | 1,951.3 |  | 2,016.2 |  | 1,228.9 |  |  |  |
Dilutive Effect of Warrants | 44.8 |  | 27.6 |  | — |  |  |  |
Dilutive Effect of Net Settlement Rights | 10.0 |  | 1.3 |  | — |  |  |  |
Diluted – Weighted Average Number of Shares | 2,006.1 |  | 2,045.1 |  | 1,228.9 |  |  |  |
Net Earnings (Loss) Per Common Share – Basic ($) | 3.29 |  | 0.27 |  | (1.94) |  |  |  |
Net Earnings (Loss) Per Common Share – Diluted (1) (2) ($) | 3.20 |  | 0.27 |  | (1.94) |  |  |  |
(1)For the year ended December 31, 2022, net earnings of $52 million (2021 – $22 million; 2020 – $nil) and common shares of 1.6 million (2021 – 1.9 million; 2020 – nil) related to the assumed exercise of the Cenovus replacement stock options, were excluded from the calculation of dilutive net earnings (loss) per share. For further information on the Company’s stock-based compensation plans, see Note 34. (2)For the year ended December 31, 2021 and December 31, 2020, NSRs of 18 million and 31 million, respectively, were excluded from the calculation of diluted weighted average number of shares as their effect would have been anti-dilutive or their exercise prices exceeded the market price of Cenovus’s common shares. B) Common Share Dividends
| 2022 |  | 2021 |  | 2020
For the years ended December 31, | Per Share |  | Amount |  | Per Share |  | Amount |  | Per Share |  | Amount
Base Dividends | 0.350 |  | 682 |  | 0.088 |  | 176 |  | 0.063 |  | 77
Variable Dividends | 0.114 |  | 219 |  | — |  | — |  | — |  | —
Total Common Share Dividends Declared and Paid | 0.464 |  | 901 |  | 0.088 |  | 176 |  | 0.063 |  | 77
The declaration of common share dividends is at the sole discretion of the Company’s Board of Directors and is considered quarterly. On February 15, 2023, the Company’s Board of Directors declared a first quarter base dividend of $0.105 per common share, payable on March 31, 2023, to common shareholders of record as at March 15, 2023. C) Preferred Share Dividends
For the years ended December 31, | 2022 |  | 2021
Series 1 First Preferred Shares | 7 |  | 7
Series 2 First Preferred Shares | 1 |  | 1
Series 3 First Preferred Shares | 12 |  | 12
Series 5 First Preferred Shares | 9 |  | 9
Series 7 First Preferred Shares | 6 |  | 5
Total Preferred Share Dividends Declared | 35 |  | 34
The declaration of preferred share dividends is at the sole discretion of the Company’s Board of Directors and is considered quarterly. On January 3, 2023, the Company paid dividends on Cenovus’s preferred shares as declared on November 1, 2022. O n February 15, 2023, the Company’s Board of Directors declared first quarter dividends for Cenovus’s preferred shares, payable on March 31, 2023, in the amount of $9 million, to preferred shareholders of record as at March 15, 2023.

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 33 -IssueDate 2022-03-24 -Section Disclosure -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS33_g70-73A__IAS33_g70-73A_TI -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfEarningsPerShareExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_EarningsPerShareAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration